Monsanto appeals damning Roundup cancer verdict

San Francisco: Monsanto on Tuesday said it is asking an appeals court to toss out a damning verdict in a landmark Roundup weed-killer cancer trial and grant it another try.

“By its appeal from the judgment and amended judgment, Monsanto also seeks appellate review of the trial court’s order denying Monsanto’s motion for new trial,” an attorney for the agrochemical colossus said in a filed notice-of-appeal.

The notice is the first step of the appeal process.

A cancer-stricken groundskeeper last month accepted a slashed award in the trial, which focused on weed-killer Roundup and a professional version of the herbicide called Ranger Pro.

Judge Suzanne Bolanos, who presided over the case in California state court, denied a Monsanto’s request for a new trial but cut the $289 million damages award to $78 million to comply with the law regarding how punitive damages awards must be calculated.

Bolanos denied a request by Monsanto to toss out the jury’s overall verdict against the company.

Jurors in August unanimously found that Monsanto acted with “malice” and that its weed killers Roundup and Ranger Pro contributed “substantially” to Dewayne “Lee” Johnson’s terminal illness.

The jury ordered Monsanto to pay $250 million in punitive damages along with compensatory damages and other costs, bringing the total figure to nearly $290 million.

Johnson, a California groundskeeper diagnosed in 2014 with non-Hodgkin’s lymphoma — a cancer that affects white blood cells — says he repeatedly used Ranger Pro while working at a school in Benicia, California.

Monsanto-parent Bayer at the time called the reduced punitive damage award a “step in the right direction” but held firm in its argument that the jury’s decision was not supported by evidence at trial.

– More to come? – Johnson’s lawsuit built on 2015 findings by the International Agency for Research on Cancer, part of the UN World Health Organization, which classified Roundup’s main ingredient glyphosate as a probable carcinogen, causing the state of California to follow suit.

Monsanto has defended the weed killer, arguing that it has a history of safe use that dates back more than 40 years.

The lawsuit is the first to accuse the product of causing cancer, but observers say a Monsanto defeat likely opens the door to thousands of other claims against the company, which was recently acquired by Germany’s Bayer.

Roundup is Monsanto’s leading product.

Founded in 1901 in St Louis, Missouri, Monsanto began producing agrochemicals in the 1940s. It was acquired by Bayer for more than $62 billion in June.

Monsanto launched Roundup in 1976 and soon thereafter began genetically modifying plants, making some resistant to Roundup.

  • Related Posts

    Civil society group SAM calls for greater transparency involving clinical trials

    The group had approached the Supreme Court, raising concerns on clinical trials in a Public Interest Litigation in 2012 Civil society group Swasthya Adhikar Manch (SAM) has called for greater…

    Different packaging, typos expose fake Mounjaro racket

    Gurugram: Colour dissimilarity to typographical errors… conspicuous differences in the packaging of counterfeit Mounjaro injections led the Drugs Control Office to crack down on the illicit sale and production of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Civil society group SAM calls for greater transparency involving clinical trials

    Civil society group SAM calls for greater transparency involving clinical trials

    Different packaging, typos expose fake Mounjaro racket

    Different packaging, typos expose fake Mounjaro racket

    To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

    To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    Rajasthan Bans 7 Sub-Standard Medicines

    Rajasthan Bans 7 Sub-Standard Medicines

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection